Tuberculous myelitis diagnosed by elevated adenosine deaminase activity in cerebrospinal fluid.
Suda
Satoshi
S
Ueda
Masayuki
M
Komaba
Yuichi
Y
Yamazaki
Mineo
M
Katsumata
Toshiya
T
Katayama
Yasuo
Y
D000243:Adenosine Deaminase / Q000134:cerebrospinal fluid*; D000995:Antitubercular Agents / Q000627:therapeutic use; D015415:Biomarkers / Q000032:analysis / Q000134:cerebrospinal fluid; D005188:False Negative Reactions; D006562:Herpes Zoster / Q000150:complications; D006801:Humans; D016867:Immunocompromised Host / Q000276:immunology; D008297:Male; D008875:Middle Aged; D009187:Myelitis / Q000134:cerebrospinal fluid* / Q000175:diagnosis* / Q000382:microbiology; D011237:Predictive Value of Tests; D016896:Treatment Outcome; D020306:Tuberculosis, Central Nervous System / Q000134:cerebrospinal fluid* / Q000175:diagnosis*; D015854:Up-Regulation / Q000502:physiology
D000995:Antitubercular Agents; D015415:Biomarkers; D000243:Adenosine Deaminase